The anaesthetic gas, nitrous oxide (N20), once regarded as chemically inert, oxidises some forms of vitamin B12. It does this both when used clinically and in the test tube, and the action is remarkably selective. As far as we know, no other pathway or substance is affected except as a result of damage to vitamin B12. Vitamin B12 that has been oxidised in this way no longer functions as a coenzyme. Thus the effect of N20 presents the biochemist and haematologist with a remarkable tool with which to explore the mode of action of vitamin B12. It presents the neurologist and neuropathologist with a new probe into the mechanism of vitamin B12 neuropathy, and finally it is a new tool with which to explore the complex field of vitamin B12-folate interrelations.
The anaesthetic gas, nitrous oxide (N20), once regarded as chemically inert, oxidises some forms of vitamin B12. It does this both when used clinically and in the test tube, and the action is remarkably selective. As far as we know, no other pathway or substance is affected except as a result of damage to vitamin B12. Vitamin B12 that has been oxidised in this way no longer functions as a coenzyme. Thus the effect of N20 presents the biochemist and haematologist with a remarkable tool with which to explore the mode of action of vitamin B12. It presents the neurologist and neuropathologist with a new probe into the mechanism of vitamin B12 neuropathy, and finally it is a new tool with which to explore the complex field of vitamin B12-folate interrelations.
The purpose of this review is to discuss current work in these fields. No attempt is made to discuss N20 from the viewpoint of an anaesthetic agent, and thereview deals only with theeffect on vitamin B12.
Chemistry
In vitro a relationship between vitamin B12 and N20 was demonstrated by Banks et al.l and others.2 Vitamin B12 is one of a group of transition-metal complexes having a metallic ion linked directly to an organic compound. These are able to activate N20, releasing free nitrogen and oxygen. The B12 itself is changed rapidly from the reduced cob(I)alamin or B12. form to the oxidised cob(III)alamin or Bl2a form, a change accompanied by rapid conversion of the grey-green colour of cob(I)alamin to a reddish-brown colour due to a mixture of cob(II) and cob(III)alamin. The latter is inactive in such pathways as methionine synthetase, which require cobalt in the fully reduced state. Cob(I)alamin + N20--Cob(III)alamin + H20 + N2 Cob(III)alamin + cob(I)alamin -+ 2 cob(II)alamin In the intact animal it is likely that the enzyme as well as the coenzyme (B12) is damaged, presumably secondary to damage to the B12, because recovery from N20 exposure takes several days, and recovery Received for publication 31 March 1980 is not more rapid if B12 is supplied, suggesting that new apoenzyme needs to be synthesised.
Clinical observations
The first clinical report of toxicity that could be ascribed to N20 was that of Lassen et At about the same time reports of a neuropathy in those exposed to excess amounts of N20 began to appear in the medical literature. By far the largest group were dentists who had developed some addiction to N20 inhalation, but a dentist and his assistant, who were exposed to N20 from a leak in defective anaesthetic equipment, were both affected, as was a young lady who obtained her N20 from capsules designed to produce whipped cream in the home.6-9
The commonest early symptom was numbness and tingling in the hands or feet. A few noticed loss of dexterity of the fingers, poor balance, or leg weakness. One At the time of writing, the effects of N20 are being studied to a variable extent in man, monkey, rat, mouse, fruit bat, and some bacteria.
EFFECTS OF N20 ON VITAMIN B12 MEDIATED PATHWAYS
Methionine synthetase In this reaction homocysteine takes up a methyl group to form methionine. The source of the methyl is usually either the al-carbon of serine or the o-carbon of glycine. The carbon unit is taken up by folate to form 5,10-methylenetetrahydropteroylpentaglutamate. Thereafter the methylene (-CH2-) is reduced to methyl (CH3-) to give 5-methyltetrahydropteroylpentaglutamate, the methyl is then transferred to cob(I)alamin to give methylcobalamin, and this is the final methyl donor.
Direct assay of enzyme activity in the liver of Sprague-Dawley rats exposed to a 50 % N20/oxygen mixture showed a substantial fall after 30 minutes' exposure, and after 6 hours methionine synthetase activity was at a virtually zero level.'5 16 The levels remain virtually undetectable for as long as exposure to N20 is continued, this particular study being terminated after 15 days. Recovery of activity after withdrawal of N20 is relatively slow, there being a steady restoration over not less than four days.
Brain methionine synthetase is depressed to an equal degree, and this too persists throughout the period of exposure to N20.17 There is no accompanying homocysteinuria. Kondo et al.18 preceded exposure to N20 with an injection of 57Co-B12. Chromatography was used to separate labelled B12 on the hepatic mutase and synthetase. With N20 exposure there was a steady fall in labelled B12 in the position of methionine synthetase.
The long recovery period after withdrawal of N20 suggests that the apoenzyme is degraded after loss of B12, and the delay in recovery is due to synthesis of new apoenzymes.
Methylmalonyl-CoA-mutase The conversion of methylmalonic acid (MMA) to succinic acid requires adenosylcobalamin as coenzyme. MMA arises from metabolism of propionic acid, valine, leucine, and isoleucine. It may be excreted in the urine in B12 deficiency, particularly if a precursor substance has been given. MMA was not detected other than in trace amounts in the urine of rats exposed to N20 even after an injection of propionic acid, whereas a group of rats on a B12-deficient diet increased their excretion from 0O1 mg to 36 mg in 24 22 showed that 3H-labelled pteroylglutamic acid (3H-PteGlu), given intraperitoneally, was taken up poorly by liver after N20 inhalation. The uptake after N20 was reduced to only 40% of the amount taken up by controls. The hepatic uptake of physiological folate analogues is also impaired after N20 inhalation. 23 The results in Table 1 show that 21 % of tetrahydropteroylglutamic acid (H4PteGlu) was taken up by liver as compared to the uptake in a control animal. The normal transport form of folate is 5-methyltetrahydrofolic acid (5-CH3-H4PteGlu) and, following N20, its hepatic uptake was reduced to 38 % of the uptake in an untreated animal. The formylfolates are less affected, values ranging from 56 to 69 % of that in controls. Inactivation of the methionine synthetase path by N20 offered an opportunity to determine if, in fact, methylfolate was trapped or whether it was metabolised by means other than through the homocysteine-methionine reaction. Figure 1 shows that rats maintained in an atmosphere of 50% N20/50 % oxygen for 10 More detailed analysis of methylfolates over the first three days (Fig. 2) shows that there is a rise in [27] [28] [29] This spectacular fall in hepatic folate is in part due to interruption of the enterohepatic circulation of methyltetrahydrofolate. Liver methylfolate is excreted into bile and thence into small gut where it is reabsorbed and again taken up by the liver. The hepatic uptake ofmethylfolate after an intraperitoneal injection in an N20-treated rat is reduced to onethird of that in control animals. The second factor leading to a fall in hepatic folate after exposure to N20 is a virtual cessation of polyglutamate synthesis from methylfolate.
Folate in other tissues
The change in folate levels in kidney, brain, and marrow after exposure to N20 follow the pattern of liver, although the fall in total folate levels is not as great.
Folate catabolism
The massive loss of folate after N20 implies excretion and/or catabolism of folate, but as yet no data have been published.
Utilisation of deoxyuridine by bone marrow
The utilisation of deoxyuridine for thymidine synthesis, a folate-dependent step, is tested in the deoxyuridine suppression test using bone marrow.303' Normal human or rat bone marrow cells will meet more than 90% of their thymidine requirements by methylation of deoxyuridine (synthetic path), and less than 10% of 3H-thymidine, added to the marrow cell suspension at a later stage, appears in DNA (salvage path). In megaloblastic anaemia there is reduced synthesis of thymidine for DNA synthesis. Thus the uptake of 3H-thymidine in megaloblastic anaemia exceeds 10%.
Marrows from patients treated with N20 give an abnormal deoxyuridine suppression test,5 and in the study of Amess et al. there was a return towards normality on the addition of vitamin B12 to the test system. Scott et al.19 reported that bone marrow from rats treated with N20 developed an abnormal deoxyuridine suppression, which, too, was improved by addition of B12, PteGlu, and 5-CHOH4PteGlu but not by the addition of 5-CH3H4PteGlu.
A more detailed examination of the role of folate analogues in thymidine synthesis in the N20-treated rat was carried out by Deacon et al. '6 The results (Table 2) were assessed against matched controls, that is, the tubes with 3H-thymidine but without deoxyuridine (= 100% value in the test) also contained whatever other additives had been added to the test mixture. Table 2 shows that the addition of B12 produced no significant improvement, unlike the situation in man and monkey,32 and the greatest improvement followed the addition of formyltetrahydrofolates. H4PteGlu produced relatively poor improvement in the methylation of deoxyuridine and methylfolate, and PteGlu no improvement. Thus those folate analogues that overcame the block in folate polyglutamate synthesis in the N20-treated rat were also the most effective in restoring a more normal deoxyuridine utilisation. The effect of N20 is bypassed, as far as folatepolyglutamate synthesis and deoxyuridine methylation are concerned, by the provision of formyltetrahydrofolate derivatives. Other folate analogues, and particularly unsubstituted tetrahydrofolate, were far less effective or not effective at all. Thus the role of B12 appears to be in the formulation of tetrahydrofolate. The source of formate is serine and/or glycine, and the formation of serine from 14C-formate and glycine was found to be impaired in all 16 patients with B12-deficient megaloblastic anaemia studied by Tikerpae and Chanarin.34 Further elucidation of the role of B12 is awaited.
NEUROLOGICAL EFFECTS OF N20
The clinical observations indicating that exposure to N20 produces a neuropathy in man have been mentioned earlier in this review. Dinn Severe neutropenia and thrombocytopenia followed the administration of N20 to man over several days,34 and in the study of Lassen et 
